查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2024694

組織庫市場報告：按產品、應用、組織類型和地區分類（2026-2034 年）

Tissue Banking Market Report by Product, Application, Tissue Type, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

2025年全球組織庫市場規模達22億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到50億美元，2026年至2034年的複合年成長率（CAGR）為9.20%。推動市場成長的因素包括研發投入激增、冷凍保存技術的進步、慢性病和遺傳疾病的增加、個人化醫療需求的成長、基因組學領域的進展、監管政策的完善、策略聯盟的建立以及研究人員意識提升的提高。

組織庫市場分析：

  • 市場主要促進因素：全球組織庫市場的發展主要得益於再生醫學的快速進步和器官移植手術的日益普及。政府措施的增加和公眾對組織捐贈意識的提高預計也將推動市場成長。此外，對更實用、更持久的組織保存和儲存技術的日益重視也是推動市場成長的因素之一。隨著慢性病和創傷病例的增加，對組織庫的需求也急劇上升，這是刺激市場成長的另一個因素。此外，醫療基礎設施的擴建，尤其是在開發中國家，也促進了市場成長。其他因素，例如對生物銀行和個人化醫療的投資增加，以及研究機構與組織庫之間合作的加強，也在推動市場成長。
  • 關鍵市場趨勢：自動化組織處理和儲存系統的發展是主要市場趨勢，有助於最大限度地縮短處理時間並減少人為錯誤。組織庫擴大採用人工智慧 (AI) 和機器學習 (ML) 來改善資料管理，這為市場成長提供了良好的前景。此外，嚴格的倫理法規迫使組織庫運營商規範其操作，進一步推動了市場成長。同時，生物製藥公司與組織庫之間日益密切的合作，以及人們對冷凍保存方法的日益關注，也正在推動市場成長。
  • 區域趨勢：北美在全球組織庫市場佔據主導地位，這得益於其完善的醫療保健基礎設施、較高的組織捐贈意識以及對醫學研究的大量投入。該地區的領先地位也歸功於其主要市場參與者的強大實力和先進技術能力。歐洲市場的成長則得益於有利的政府環境和健全的公共衛生體系。亞太地區組織庫市場的成長則得益於醫療保健支出的激增、生物銀行建設的不斷擴展以及組織移植數量的增加。
  • 競爭格局：組織庫產業的主要市場參與者包括 AMS Biotechnology、Beckman Coulter Inc.（丹納赫公司）、Bio-Rad Laboratories Inc.、Brooks Life Sciences Inc.（Brooks Automation Inc.）、Eppendorf AG、Merck KGaA、PHCific Corporation、QIA Automation Inc.）、Eppendorf AG、Merck KGaA、PHCific Corporation、QIAGEN NV、Taylor Inc. LLC（Avantor Inc.）。
  • 挑戰與機會：市場挑戰包括嚴格的監管要求、與組織提供和處理相關的倫理問題，以及先進保存方法的高成本。保存組織的品質和安全至關重要，需要嚴格遵守相關標準。在某些地區，認知度低和文化障礙限制了組織提供率。然而，市場發展也存在著許多機會，例如公眾意識的提高和教育的普及，這些都將促進組織提供率的提升。保存技術和解決方案提供者也應關注如何提高成本效益。

組織庫市場的發展趨勢：

加大研發投入

全球組織庫市場的主要驅動力是研發投入的增加，尤其是在再生醫學和個人化醫療領域。科學界和醫學界在疾病認知和治療方法的進步顯著提高了組織樣本的可用性，進一步推動了市場成長。這些樣本在闡明疾病的生物學機制、測試新藥療效以及識別可能受益於特定藥物的患者群體方面發揮著至關重要的作用。隨著幹細胞療法和基因編輯等領域的研究進展，對特定組織樣本的依賴性日益增強，進一步推動了對易於獲取且保存完好的組織庫的需求。例如，加州大學舊金山分校最近推出了世界上首個使用新冠肺炎長期病患樣本的組織庫。此舉是基於一項研究，該研究表明病毒可能在體內持續存在，這或許是了解這種致殘性疾病病因並開發有效治療方法的關鍵。

冷凍保存技術的進步

冷凍保存技術的發展是全球組織庫市場的主要驅動力之一。冷凍保存是一種在冰點以下保存活體組織和細胞並保持其活性的有效方法。科技的快速發展正在加速這一進程，並顯著提高保存組織的品質和耐久性。此外，新型冷凍保護劑和冷卻技術，例如玻璃化冷凍技術，正在不斷研發，該技術可以防止冰晶的形成，從而避免對細胞結構造成損害。同時，冷凍保存的自動化提高了操作效率，有助於最大限度地減少人為錯誤並提高處理能力，從而促進市場成長。

慢性病和遺傳性疾病盛行率增加

遺傳性疾病和慢性病的日益普遍是推動全球組織庫市場發展的主要因素之一。沙烏地阿拉伯一項全國性調查顯示，成年男性糖尿病盛行率為14.8%，而女性盛行率為11.7%，低於男性。對於癌症、心血管疾病和糖尿病等慢性病，需要進行廣泛的研究以了解其病理生理機制並開發有效的治療方法。組織庫為此類研究提供了至關重要的資源，它們提供種類繁多的生物檢體，這些樣本對於闡明疾病機制、開發新藥和檢驗治療效果至關重要。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球組織庫市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 裝置
    • 主要部分
      • 冷凍保存裝置
      • 解凍裝置
      • 品管設備
      • 其他
  • 媒體和耗材

第7章 市場區隔：依應用領域分類

  • 治療
  • 醫學調查
  • 其他

第8章 市場區隔：依組織類型分類

  • 心血管組織
  • 肺組織
  • 腎臟組織
  • 胰臟組織
  • 肝組織
  • 眼組織
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • AMS Biotechnology
    • Beckman Coulter Inc.（Danaher Corporation）
    • Bio-Rad Laboratories Inc.
    • Brooks Life Sciences Inc.（Brooks Automation Inc.）
    • Eppendorf AG
    • Merck KGaA
    • PHC Corporation
    • QIAGEN NV
    • Sartorius AG
    • Taylor-Wharton
    • Thermo Fisher Scientific Inc.
    • VWR International LLC（Avantor Inc）
Product Code: SR112026A4764

The global tissue banking market size reached USD 2.2 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 5.0 Billion by 2034, exhibiting a growth rate (CAGR) of 9.20% during 2026-2034. The burgeoning research and development (R&D) investments, advancements in cryopreservation, the rise in chronic diseases and genetic disorders, growing demand for personalized medicine, improvements in genomics, regulatory advancements, strategic collaborations, and enhanced awareness among researchers are some of the factors boosting the market growth.

TISSUE BANKING MARKET ANALYSIS :

  • Major Market Drivers: The global market for tissue banking is driven by the expediating progress in regenerative medicine and growing adoption of organ transplantation procedures. Increasing number of initiatives undertaken by the government and rising awareness regarding tissue donation are other factors expected to drive the market growth. Moreover, surging focus on the development of tissue preservation and storage techniques that are more viable and offer longer shelf life is another growth-inducing factor for the market. With the increasing rate of chronic diseases and trauma cases, the demand for tissue banking is growing exponentially, which is another factor stimulating the market growth. Apart from this, expanding healthcare infrastructure especially in developing countries is facilitating the market growth. Other factors, such as mounting investments into biobanking and personalized medicine and escalating collaborations among research institutions and tissue banks, are promoting the market growth.
  • Key Market Trends: The development of automated tissue processing and preservation systems, which has helped minimize the amount of time taken to do a process with reduced human error, is one of the primary market trends. The escalating use of artificial intelligence (AI) and machine learning (ML) in tissue banking to improve data management is creating a positive outlook for the market growth. In line with this, stringent ethical regulations has compelled the tissue baking players to standardize their operations, which is further fueling the market growth. Moreover, the escalating collaboration between biopharmaceutical companies and tissue banks and surging attention on the cryopreservation methods are propelling the market growth.
  • Geographical Trends: North America holds a leading share in the global tissue banking market as it is backed by a strong healthcare infrastructure, higher awareness about tissue donation, and significant investments in medical research. The region's dominance is also due to the strong presence of key market players and advanced technological capabilities. Europe's market growth is propelled by favorable governmental contexts and robust public health systems. Asia-Pacific's tissue banking market is bolstered by the burgeoning healthcare expenditure, expanding biobanking initiatives, and growing number of tissue transplantation.
  • Competitive Landscape: Some of the major market players in the tissue banking industry include AMS Biotechnology, Beckman Coulter Inc. (Danaher Corporation), Bio-Rad Laboratories Inc., Brooks Life Sciences Inc. (Brooks Automation Inc.), Eppendorf AG, Merck KGaA, PHC Corporation, QIAGEN N.V., Sartorius AG, Taylor-Wharton, Thermo Fisher Scientific Inc., VWR International LLC (Avantor Inc), among many others.
  • Challenges and Opportunities: The factors creating challenges for the market include stringent regulatory requirements, ethical issues about tissue donation and processing, and the high costs of sophisticated storage methods. The quality and safety of stored tissues is aptly the primary concern, which entails adherence to stringent standards. Tissue donation rates are limited in some parts due to low level of awareness and cultural barriers. However, they also offer various opportunities for market development, such as the increasing tissue donation rates due to burgeoning public awareness and education. Affordability is another factor that preservation technology and storage solution providers can consider to address.

TISSUE BANKING MARKET TRENDS:

Increasing Investments in Research and Development

The global tissue banking market is predominantly driven in growth by the increasing investment in R&D, especially for regenerative medicine and personalized therapies. With the advancements in disease understanding and treatment by scientific and medical communities, there is a significant growth in tissue sample donations, which is further fueling the market growth. These samples are key to understanding the biology of disease, testing new drugs for potential use in patients, and identifying patient populations that may benefit from a particular drug. As research progresses in fields such as stem cell therapy and gene editing, it thrusts the reliance on specific tissue samples, further increasing the demand for well-preserved banks of tissues accessible by everyone. For instance, recently, UC San Francisco launched the world's first tissue bank with samples donated by patients with long COVID. The move follows research indicating that the virus can continue to linger throughout the body and may hold the key to understanding the cause of the debilitating disorder and lead to effective treatments.

Advances in Cryopreservation Technologies

The development of cryopreservation technologies is one of the major factors which is pushing the global tissue banking market. Cryopreservation is an effective way to store living tissue and cells below freezing temperatures while keeping it viable. Rapidly advancing technologies have accelerated this process, making the quality of preserved tissues and their durability much better. Additionally, new cryoprotectants and cooling techniques are developed, such as vitrification that prevents ice crystal formation, which can otherwise damage cell structures. Moreover, automation in cryopreservation further automates the operations and helps in minimizing human error and increasing throughput, which is bolstering the market growth.

Growing Prevalence of Chronic Diseases and Genetic Disorders

The growing incidence of genetic diseases and chronic conditions is one of the primary factor accelerating the global tissue banking market. As per the national survey carried out in Saudi population, Diabetes Mellitus (DM) among adult males and females were estimated with prevalence rates 14.8% for male, while it was lower for female group where 11.7%. Chronic conditions such as cancer, cardiovascular diseases, and diabetes require extensive research to understand their pathophysiology and develop effective treatments. Tissue banks provide critical resources for this research by offering a diverse array of biological samples, which are essential for studying disease mechanisms, developing new drugs, and testing treatment efficacy.

TISSUE BANKING MARKET SEGMENTATION:

Breakup by Product:

  • Equipment
    • Cryopreservation Equipment
    • Thawing Equipment
    • Quality Control Equipment
    • Others
  • Media and Consumables

Equipment accounts for the majority of the market share

The equipment segment is driven by the increasing demand for advanced and reliable systems for tissue preservation and analysis. Technological advancements, such as automation and improved cryopreservation techniques, are crucial in enhancing the efficiency and accuracy of tissue handling and storage. The rise in research activities and clinical trials necessitates state-of-the-art equipment to ensure high-quality and reproducible results. Additionally, the growing focus on personalized medicine and regenerative therapies fuels the need for specialized equipment capable of managing diverse and complex tissue samples. Regulatory requirements for quality and safety standards further drive the adoption of sophisticated equipment. Increased investments in healthcare infrastructure and the expansion of tissue banks globally also contribute to the demand for advanced equipment.

Breakup by Application:

  • Therapeutics
  • Medical Research

Therapeutics holds the largest share of the industry

The therapeutics segment is driven by the increasing demand for personalized medicine, which necessitates the use of specific, high-quality tissue samples to tailor treatments to individual genetic profiles. Advances in genomics and biotechnology further fuel this growth, as they enable researchers and clinicians to better understand complex disease mechanisms and develop targeted therapies. Additionally, the rising prevalence of chronic diseases and genetic disorders accelerates the need for innovative therapeutic solutions, leading to a surge in research and development activities. Technological advancements in drug discovery, including high-throughput screening and sophisticated bioinformatics tools, are also pivotal, as they rely on diverse and well-characterized biological samples to identify and validate new therapeutic targets. The growing emphasis on regenerative medicine and cell therapies, such as stem cell treatments and tissue engineering, drives demand for robust tissue banking infrastructure, which provides essential materials for these cutting-edge therapies.

Breakup by Tissue Type:

  • Cardiovascular Tissue
  • Lung Tissue
  • Kidney Tissue
  • Pancreas Tissue
  • Liver Tissue
  • Eye Tissue

Cardiovascular Tissue represents the leading market segment

The cardiovascular tissue segment is driven by the increasing prevalence of cardiovascular diseases (CVDs), which are among the leading causes of mortality globally. This surge in CVD cases necessitates extensive research and development efforts, fueling the demand for high-quality cardiovascular tissues for studying disease mechanisms, developing innovative treatments, and testing therapeutic interventions. Advances in tissue engineering and regenerative medicine are also pivotal, as they enable the creation and use of cardiovascular tissues for developing personalized therapies and improving patient outcomes. The growing emphasis on personalized medicine further drives demand, as clinicians seek tissue samples that match individual patient profiles for more effective treatment plans. Additionally, ongoing advancements in biobanking technologies, including improved preservation methods and better tissue characterization techniques, enhance the quality and availability of cardiovascular tissues.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest tissue banking market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for tissue banking.

The North America regional market is driven by the increasing investments in healthcare research and biotechnology, which significantly bolster the demand for high-quality tissue samples. The presence of advanced research institutions and a robust pharmaceutical industry in the region accelerates the need for well-maintained tissue banks to support innovative studies in regenerative medicine, personalized therapies, and drug development. Additionally, the growing prevalence of chronic diseases and genetic disorders in North America drives the need for diverse tissue samples to understand disease mechanisms and develop effective treatments. Technological advancements in cryopreservation and tissue storage further enhance the market, providing solutions that extend the viability of preserved tissues and improve overall research quality. The regulatory landscape in North America also plays a crucial role; stringent standards and guidelines ensure the quality and safety of tissue banking practices, which in turn fosters trust and reliability in tissue banks.

COMPETITIVE LANDSCAPE:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the tissue banking industry include AMS Biotechnology, Beckman Coulter Inc. (Danaher Corporation), Bio-Rad Laboratories Inc., Brooks Life Sciences Inc. (Brooks Automation Inc.), Eppendorf AG, Merck KGaA, PHC Corporation, QIAGEN N.V., Sartorius AG, Taylor-Wharton, Thermo Fisher Scientific Inc., VWR International LLC (Avantor Inc), etc. ()
  • Key players in the tissue banking market are actively engaged in a variety of strategic initiatives to enhance their market position and drive innovation. Leading companies are investing heavily in R&D to advance cryopreservation technologies, improve tissue storage methods, and develop new applications for tissue samples. This includes implementing cutting-edge automation and digital solutions to streamline operations, increase efficiency, and ensure high-quality preservation of biological materials. Additionally, these players are expanding their global footprint by establishing new tissue banks and forming strategic partnerships with academic institutions, biopharmaceutical companies, and healthcare organizations. To address the growing demand for specialized and well-characterized tissue specimens, key players are also focusing on diversifying their tissue collections and incorporating advanced genomic and molecular characterization techniques. Moreover, regulatory compliance and the establishment of rigorous quality control standards are priorities, ensuring that their practices meet international guidelines and enhance the reliability of tissue resources.

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Tissue Banking Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Equipment
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Cryopreservation Equipment
      • 6.1.2.2 Thawing Equipment
      • 6.1.2.3 Quality Control Equipment
      • 6.1.2.4 Others
    • 6.1.3 Market Forecast
  • 6.2 Media and Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Therapeutics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Medical Research
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Tissue Type

  • 8.1 Cardiovascular Tissue
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Lung Tissue
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Kidney Tissue
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Pancreas Tissue
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Liver Tissue
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Eye Tissue
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AMS Biotechnology
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Beckman Coulter Inc. (Danaher Corporation)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Bio-Rad Laboratories Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Brooks Life Sciences Inc. (Brooks Automation Inc.)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Eppendorf AG
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 Merck KGaA
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 PHC Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 QIAGEN N.V.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Sartorius AG
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Taylor-Wharton
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 VWR International LLC (Avantor Inc)
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Tissue Banking Market: Major Drivers and Challenges
  • Figure 2: Global: Tissue Banking Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Tissue Banking Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Tissue Banking Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Tissue Banking Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Tissue Banking Market: Breakup by Tissue Type (in %), 2025
  • Figure 7: Global: Tissue Banking Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Tissue Banking (Equipment) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Tissue Banking (Equipment) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Tissue Banking (Media and Consumables) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Tissue Banking (Media and Consumables) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Tissue Banking (Therapeutics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Tissue Banking (Therapeutics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Tissue Banking (Medical Research) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Tissue Banking (Medical Research) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Tissue Banking (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Tissue Banking (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Tissue Banking (Cardiovascular Tissue) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Tissue Banking (Cardiovascular Tissue) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Tissue Banking (Lung Tissue) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Tissue Banking (Lung Tissue) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Tissue Banking (Kidney Tissue) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Tissue Banking (Kidney Tissue) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Tissue Banking (Pancreas Tissue) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Tissue Banking (Pancreas Tissue) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Tissue Banking (Liver Tissue) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Tissue Banking (Liver Tissue) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Tissue Banking (Eye Tissue) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Tissue Banking (Eye Tissue) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Tissue Banking (Other Tissue Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Tissue Banking (Other Tissue Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: North America: Tissue Banking Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: North America: Tissue Banking Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: United States: Tissue Banking Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: United States: Tissue Banking Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Canada: Tissue Banking Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Canada: Tissue Banking Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Asia-Pacific: Tissue Banking Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Asia-Pacific: Tissue Banking Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: China: Tissue Banking Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: China: Tissue Banking Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Japan: Tissue Banking Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Japan: Tissue Banking Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: India: Tissue Banking Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: India: Tissue Banking Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: South Korea: Tissue Banking Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: South Korea: Tissue Banking Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Australia: Tissue Banking Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Australia: Tissue Banking Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Indonesia: Tissue Banking Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Indonesia: Tissue Banking Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Others: Tissue Banking Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Others: Tissue Banking Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Europe: Tissue Banking Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Europe: Tissue Banking Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Germany: Tissue Banking Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Germany: Tissue Banking Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: France: Tissue Banking Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: France: Tissue Banking Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: United Kingdom: Tissue Banking Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: United Kingdom: Tissue Banking Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Italy: Tissue Banking Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Italy: Tissue Banking Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Spain: Tissue Banking Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Spain: Tissue Banking Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Russia: Tissue Banking Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Russia: Tissue Banking Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Others: Tissue Banking Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Others: Tissue Banking Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Latin America: Tissue Banking Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Latin America: Tissue Banking Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Brazil: Tissue Banking Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Brazil: Tissue Banking Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Mexico: Tissue Banking Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Mexico: Tissue Banking Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Others: Tissue Banking Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Others: Tissue Banking Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Middle East and Africa: Tissue Banking Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Middle East and Africa: Tissue Banking Market: Breakup by Country (in %), 2025
  • Figure 80: Middle East and Africa: Tissue Banking Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Global: Tissue Banking Industry: SWOT Analysis
  • Figure 82: Global: Tissue Banking Industry: Value Chain Analysis
  • Figure 83: Global: Tissue Banking Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Tissue Banking Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Tissue Banking Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Tissue Banking Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Tissue Banking Market Forecast: Breakup by Tissue Type (in Million USD), 2026-2034
  • Table 5: Global: Tissue Banking Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Tissue Banking Market: Competitive Structure
  • Table 7: Global: Tissue Banking Market: Key Players